186 related articles for article (PubMed ID: 5071688)
21. Gordon L. Amidon: Very Sustained Drug Absorption.
Donovan MD; Polli JE; Langguth P; Tamai I; Vig B; Yu LX
J Pharm Sci; 2015 Sep; 104(9):2650-63. PubMed ID: 26053319
[No Abstract] [Full Text] [Related]
22. [Modern concept of the drug form].
Lopattin PV
Farmatsiia; 1977; 26(6):30-3. PubMed ID: 598523
[No Abstract] [Full Text] [Related]
23. Proceedings: Mechanisms of drug absorption and of drug solution.
Jollow DJ
Rev Can Biol; 1973; 32():Suppl:7-19. PubMed ID: 4777606
[No Abstract] [Full Text] [Related]
24. Generic equivalence and non-equivalence of drugs.
Smith RN
Lancet; 1972 Sep; 2(7776):528-30. PubMed ID: 4115582
[No Abstract] [Full Text] [Related]
25. Dose-dependent drug metabolism during the absorptive phase.
Barr WH; Aceto T; Chung M; Shukur M
Rev Can Biol; 1973; 32():Suppl:33-42. PubMed ID: 4791683
[No Abstract] [Full Text] [Related]
26. The potential clinical significance of differences in bioavailability.
Hosp Formul; 1976 Sep; 11(9):484, 487-8. PubMed ID: 10316482
[No Abstract] [Full Text] [Related]
27. [Basic definitions from the field of biopharmacy and pharmacokinetics].
Krówczyński L; Danek A
Pol Tyg Lek; 1976 Apr; 31(14):601-2. PubMed ID: 1272953
[No Abstract] [Full Text] [Related]
28. Panel discussion: practical importance of generic equivalence.
Ann Clin Res; 1974; 6(0):suppl 11:79-88. PubMed ID: 4212521
[No Abstract] [Full Text] [Related]
29. The importance of biopharmaceutics in pharmaceutical education.
Mezei M
Pharmazie; 1971 Nov; 26(11):656-8. PubMed ID: 5154315
[No Abstract] [Full Text] [Related]
30. Bioavailability of peroral dosage forms.
Ritschel WA
Boll Chim Farm; 1973 Mar; 112(3):137-62. PubMed ID: 4198518
[No Abstract] [Full Text] [Related]
31. [Pharmacokinetic methods for the evaluation of intestinal absorption].
Kübler W
Z Kinderheilkd; 1970; 108(3):187-96. PubMed ID: 5475029
[No Abstract] [Full Text] [Related]
32. Biopharmaceutics and applied pharmacy.
Krówczyński L
Pharmazie; 1971 Nov; 26(11):659. PubMed ID: 5154316
[No Abstract] [Full Text] [Related]
33. Biologic availability and therapeutic equivalence.
Arnold JD; Sicé J
J Clin Pharmacol; 1976 Oct; 16(10 Pt 2):546-9. PubMed ID: 977793
[No Abstract] [Full Text] [Related]
34. Pharmacokinetics in relation to age.
Gladtke E
Boll Chim Farm; 1973 May; 112(5):333-41. PubMed ID: 4761111
[No Abstract] [Full Text] [Related]
35. Comparative performance of equivalent drugs.
J Indiana State Med Assoc; 1970 May; 63(5):446. PubMed ID: 5447481
[No Abstract] [Full Text] [Related]
36. [Significance of biopharmaceutics for practical drug therapy].
Dettli L
Helv Med Acta Suppl; 1970 Jun; ():Suppl 50:57-63. PubMed ID: 5288609
[No Abstract] [Full Text] [Related]
37. [Biopharmacy].
Modrzejewski F
Pharmazie; 1971 Nov; 26(11):661. PubMed ID: 5154318
[No Abstract] [Full Text] [Related]
38. Bioavailability, clinical effectiveness, and the public interest.
Levy G
Pharmacology; 1972; 8(1):33-43. PubMed ID: 4644654
[No Abstract] [Full Text] [Related]
39. A time to speak out on bioequivalence and therapeutic equivalence.
Dettelbach HR
J Clin Pharmacol; 1986; 26(5):307-8. PubMed ID: 2871052
[No Abstract] [Full Text] [Related]
40. [Biopharmacy and pharmacokinetics].
Janků I
Pharmazie; 1971 Nov; 26(11):660. PubMed ID: 5154317
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
